Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Restructuring Costs (2020 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Restructuring Costs over the past 6 years, most recently at -$115000.0 for Q1 2025.

  • Quarterly results put Restructuring Costs at -$115000.0 for Q1 2025, down 114.92% from a year ago — trailing twelve months through Feb 2025 was $32.4 million (up 3401.62% YoY), and the annual figure for FY2025 was -$1.7 million, down 205.5%.
  • Restructuring Costs for Q1 2025 was -$115000.0 at Lifecore Biomedical, Inc. \De\, down from $31.6 million in the prior quarter.
  • Over the last five years, Restructuring Costs for LFCR hit a ceiling of $31.6 million in Q2 2024 and a floor of -$115000.0 in Q1 2025.
  • Median Restructuring Costs over the past 5 years was $1.0 million (2022), compared with a mean of $3.4 million.
  • Biggest five-year swings in Restructuring Costs: soared 395050.0% in 2024 and later plummeted 114.92% in 2025.
  • Lifecore Biomedical, Inc. \De\'s Restructuring Costs stood at $627000.0 in 2021, then decreased by 10.21% to $563000.0 in 2022, then plummeted by 72.11% to $157000.0 in 2023, then soared by 20035.03% to $31.6 million in 2024, then tumbled by 100.36% to -$115000.0 in 2025.
  • The last three reported values for Restructuring Costs were -$115000.0 (Q1 2025), $31.6 million (Q2 2024), and $771000.0 (Q1 2024) per Business Quant data.